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Abstract
Homeostasis of the central nervous system (CNS) is strictly regulated by a unique struc-
ture of blood vessels, the blood-brain barrier (BBB). Experimental and clinical evidence 
has revealed that abnormalities in the BBB in chronic inflammatory diseases such as mul-
tiple sclerosis (MS). By using an animal model of MS, we identified novel neuro-immune 
crosstalk to explain how pathogenic immune cells enter the CNS to disrupt its homeosta-
sis, a phenomenon we named the gateway reflex. Regional neural inputs such as grav-
ity, electricity, pain or chronic stress cause specific neural activation to create a gateway 
of immune cells, particularly pathogenic ones, at specific blood vessels. Moreover, the 
recently discovered stress-induced gateway reflex uncovered a stress-induced neural 
link between the brain, gastrointestine, and heart. Thus, the gateway reflex is critical for 
the homeostasis of various organs, and aberrant activation of neural pathways by the 
gateway reflex disrupts normal organ homeostasis. The inflammatory reflex is another 
mechanism for local neuro-immune interactions. It potently exerts a cholinergic anti-
inflammatory effect on various disease conditions. In this section, we discuss emerging 
roles for local neuro-immune interactions, with a special focus on the gateway reflex.
Keywords: gateway reflex, experimental autoimmune encephalomyelitis, central 
nervous system, chemokines, pathogenic CD4+ T cells
1. Introduction
A variety of environmental stimulations such as light, temperature, sound, and so on acti-
vates specific neurons to trigger biological responses. Gravity is another stimulus on land 
animals. Without sufficient gravity stimulation, physical functions including bone mass and 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
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muscle strength change, as observed in astronauts who stayed in the International Space 
Station [1, 2]. In addition to these physical stimulations, various events in daily social interac-
tions associated with psychological alterations including anxiety, mental stresses or positive 
emotions are also stimulatory factors that trigger specific neural pathways to affect body 
functions. A well-studied mechanism to cope with these stimulations includes the release of 
glucocorticoids via the hypothalamus-pituitary-adrenal grand (HPA) axis, which systemi-
cally changes various physiological functions including the immune system [3, 4]. Besides 
this systemic regulation, we and other groups have identified local regulations of the inflam-
matory status by various environmental cues that cause specific neural activations. Here we 
summarize examples of specific neuro-immune interactions in organ homeostasis.
2. Main text
2.1. Gravity gateway reflex
The central nervous system (CNS) is considered an immune privileged site due to struc-
tural protections by the blood-brain barrier (BBB) [5]. The BBB is formed by tight cell-cell 
interactions between blood endothelial cells and tight liner sheets, a structure that lies outside 
the basement membrane and consists of pericytes, neurons, microglias, and astrocytes. Tight 
junctions by the interactions of tight-junction molecules including claudins and occludins are 
critical for the cell-cell interactions in the BBB that sequester cerebrospinal fluid from circulat-
ing blood components [6]. However, despite the BBB, there exist a certain number of immune 
cells in the CNS to prevent brain tumors and viral infections. In pathological conditions of 
the CNS, excessive immune cells from the blood accumulate from the breached BBB to cause 
chronic inflammatory diseases including multiple sclerosis (MS). It is also known that brain 
micro-inflammation is associated with neurodegenerative disorders such as Parkinson’s dis-
ease and Alzheimer’s disease [7]. Inflammatory cytokines including IL-1β, IL-17A, IFNγ and 
TNFα increase the BBB permeability, while chemokines recruit immune cells from the blood 
to cause inflammation [8–10]. However, where and how local CNS inflammation is induced 
in the BBB is poorly understood.
MS is a chronic inflammatory disease of the CNS. It is characterized by impairments in sen-
sory, motor, autonomic, and neurocognitive functions due to autoimmune-mediated demy-
elination in CNS nerves [11]. Genetic factors strongly contribute to the MS pathogenesis, 
and genome-wide association studies (GWAS) have revealed that certain alleles of major 
histocompatibility complex (MHC) class II genes including HLA-DRB1*15:01 and HLA-
DRB1*13:03 and genes involved in CD4+ T cell activation and homeostasis such as IL-2Rα 
and IL-7R are genetically associated with MS development [12–15]. These genetic results 
strongly suggest that autoreactive CD4+ T cells play a vital role in the MS pathogenesis and 
are supported by animal models of MS including experimental autoimmune encephalomy-
elitis (EAE) [16–19]. Using an adaptive transfer model of EAE [20], we investigated how and 
where myelin-autoreactive pathogenic CD4+ T cells initially invade the CNS. Whole-mount 
sections of adult mice with pathogenic CD4+ T cell transfer sacrificed just before the onset of 
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EAE symptoms revealed that pathogenic CD4+ T cells mainly accumulated at the L5 spinal 
cord, around the dorsal vessels in particular [18]. On the other hand, no accumulation was 
observed in the brain or upper spinal levels at the preclinical time point of EAE. Various che-
mokines including CCL20 attract type-17 CD4+ T (Th17) cells, which are known to have a key 
pathogenic role in EAE [21, 22], to accumulate more in the dorsal vessels of L5 than L1 cord. 
Indeed, CCL20 neutralization or deficiency of its receptor, CCR6, on pathogenic CD4+ T cells 
abrogated the cell accumulation in the L5 spinal cord [18].
Interestingly, even without EAE induction, chemokine levels were higher in the L5 dorsal 
vessels than in the L1 cord. These results suggest a distinct property of L5 dorsal vessels both 
in the presence and absence of pathogenic CD4+ T cells. The L5 spinal level has the largest 
dorsal root ganglion (DRG) in both human and mice, and it is known that sensory neurons 
in the L5 DRG distribute to the soleus muscles, the main anti-gravity muscles of the body 
[23, 24]. These facts led us to hypothesize a link between gravity, L5 vessels and local inflam-
mation. We examined this possibility using a ground experiment employed by the National 
Aeronautics and Space Administration (NASA) and Japan Aerospace Exploration Agency 
(JAXA) [25, 26]. The tail suspension method puts mice in a handstand position, such that 
the hind limbs are released from gravity stimulation. As hypothesized, after the tail suspen-
sion, chemokine expressions of the L5 dorsal vessels were reduced and pathogenic CD4+ 
T cells hardly invaded the L5 cord. Chemokines were instead upregulated at the cervical 
cords as though another gateway for immune cells was formed by the greater gravity stimu-
lation on the arm muscles imposed by the tail suspension [18]. Consistently, the tail suspen-
sion significantly reduced the expression of a neural activation marker, c-Fos, in the L5 DRG, 
suggesting a correlation between regional neural activation and local inflammation in the 
CNS. Consistently, stimulation of the soleus muscles by weak electric pulses, which mimic 
gravity-mediated sensory activation, during tail suspension restored chemokine expression, 
pathogenic CD4+ T cell accumulation, and c-Fos levels at the L5 dorsal vessels [18]. That 
study identified L5 dorsal vessels as a blood vessel gateway for immune cells including patho-
genic CD4+ T cells to the CNS, and revealed that regional sensory neural activation by grav-
ity affects CNS homeostasis and causes local inflammation at L5 dorsal blood vessels when 
CNS-autoreactive pathogenic CD4+ T cells are present. This phenomenon, which represents 
a novel neuro-immune interaction, was termed the “gateway reflex” [27–34]. Since then, we 
have found various types of gateway reflexes depending on the neural stimulation. Thus, the 
abovementioned example is known as the gravity gateway reflex (Figure 1).
How the regional neural pathway by gravity stimulation regulates chemokine expressions in 
L5 blood vessels is an important question. Contribution of the autonomic nervous system was 
suggested. In fact, neural activation examined by c-Fos expression was higher in sympathetic 
ganglions at the L5 cord than at the L1 cord. In addition, the blood flow speed of the L5 dorsal 
vessels but not of other blood vessels including the L1 dorsal vessels, femoral artery or por-
tal vein, slowed after tail suspension. Functionally, the treatment of mice with β-adrenergic 
receptor antagonists or chemical sympathectomy inhibited chemokine expressions, the accu-
mulation of pathogenic CD4+ T cells at the L5 dorsal vessels, and the clinical scores of EAE 
[18]. Norepinephrine is one of the major neurotransmitters of sympathetic nerves. Indeed, 
in vitro experiments suggest that norepinephrine enhances chemokine expressions from 
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endothelial cell lines with activation of the inflammation amplifier [18]. The inflammation 
amplifier is a molecular mechanism that operates in nonimmune cells including endothelial 
cells to produce a large amount of pro-inflammatory mediators including chemokines, cyto-
kines and growth factors upon the concomitant activation of two transcription factors, NF-κB 
and STAT3 [35–37]. The co-activation of NF-κB and STAT3 by cytokines such as IL-17, IL-6, 
and TNFα augments NF-κB activity and upregulates NF-κB-target genes including chemo-
kines, which can be further enhanced by neurotransmitters including norepinephrine and 
ATP (Figure 2) [18, 38]. The contribution of nonimmune cells to chronic inflammation via 
the inflammation amplifier has been found significant in the development of various dis-
ease models and evidence of inflammation amplifier activation has been observed in patients 
with MS, rheumatoid arthritis, atherosclerosis, and chronic rejection after lung transplanta-
tion [39–45]. Thus, the gateway reflex represents novel local neuro-immune communication 
involving the activation of specific sensory and sympathetic neurons for the formation of 
blood vessel gateways (Figure 1). Because chemokine levels are constantly higher at the L5 
dorsal vessels under normal conditions without EAE induction, the gateway reflex could 
have a physiological role as well. Indeed, it is reported in mice that after a learning task, 
CD4+ T cells, but not CD8+ T cells, accumulated in the CNS, and mice devoid of CD4+ T cells 
showed impaired learning performance and neurogenesis in the hippocampus [46–48]. The 
gravity gateway reflex may be utilized by these cells to enter the CNS to maintain and/or 
control the homeostasis and function of the CNS.
Figure 1. Gravity gateway reflex. Stimulation of the soleus muscles by gravity (1) induces the activation of specific 
sensory nerves (2). The cell bodies of these sensory neurons are located at the dorsal root ganglion (DRG) of the fifth 
lumbar (L5) spinal cord (3). Neural activation via the L5 DRG neurons travels to the L5 sympathetic ganglion (4) and 
induces the activation of sympathetic nerves (5), which results in norepinephrine (NE) secretion (6) at the L5 dorsal 
vessels. NE enhances the inflammation amplifier in the L5 dorsal vessels, causing an upregulation of chemokines and 
recruiting pathogenic CD4+ T cells from the vessels (7).
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2.2. Electric gateway reflex
The gateway reflex is not specific to the soleus-L5 axis because electrical stimulation of 
regional sensory neurons in different muscles can induce the formation of gateways in the 
dorsal vessels of different spinal cord levels. For instance, electric stimulation of the quad-
riceps, which are controlled by the L3 DRG neurons, induces chemokine expressions at the 
L3 dorsal vessels. Similarly, electric stimulations of the triceps upregulate chemokines at the 
dorsal vessels of the cervical to thoracic spinal cords (Figure 3) [18]. These results suggest that 
the electric gateway reflex can be artificially controlled, raising a possibility for a therapeutic 
application of the gateway reflex to various CNS diseases like MS and brain tumors.
2.3. Pain gateway reflex
We have examined whether other sensory stimulations can also generate the gateway reflex. 
We focused on pain because it is a tonic sensory stimulation [49, 50] and associated with 
various diseases that significantly compromise quality of life [51]. Some studies suggest that 
Figure 2. Inflammation amplifier. Co-activation of the transcription factors NF-κB and STAT3 in nonimmune cells 
such as endothelial cells and fibroblasts induces a synergistic effect on the production of inflammation factors such 
as chemokines, growth factors, and IL-6. Various factors activating NF-κB and STAT3 including IL-17, TNFα, and IL-6 
can drive the amplifier. Secreted IL-6 is thought to act on nonimmune cells to form a positive feedback loop for this 
synergistic effect. Massive production of chemokines and growth factors by the inflammation amplifier play an essential 
role in the pathogenesis of many inflammatory diseases. DC, dendritic cells; GF, growth factors; NK, natural killer cells; 
NE, norepinephrine; Th, helper T cells.
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pain occurrence is positively correlated with disease severity in MS [52–54], and mechanical 
allodynia and thermal hyperalgesia are induced in mice during EAE [55, 56]. In the adoptive 
transfer EAE model we used, recipient mice that received myelin-specific pathogenic CD4+ 
T cells developed transient paralysis, but then recovered and hardly relapsed even 100 days 
later. To examine how pain affects EAE symptoms, we induced pain sensation in mice by 
partial ligation of the middle branch of the trigeminal nerves, which are composed of sensory 
nerves alone [57]. Pain induction with pathogenic CD4+ T cell transfer significantly worsened 
the paralysis. By contrast, pain medicines improved EAE development [19]. Thus, pain is 
not simply an alert of the disease or injury status, but it also has a pathogenic role, trigger-
ing EAE relapse. Since a large part of MS patients show relapse and remission and pain is 
more frequently claimed by MS patients with higher disease scores [52, 53], we examined 
the effects of pain induction in mice that had recovered from EAE (EAE-recovered mice). As 
expected, EAE-recovered mice showed a clear sign of relapse after the partial ligation of the 
trigeminal nerve or injection of pain-inducing chemicals such as substance P and capsaicin 
[19]. As described above, under normal conditions, the blood vessel gateway for immune cells 
is the L5 dorsal vessels due to the effect of gravity [18]. To identify specific blood vessels that 
act as a gateway for immune cells that cause the pain-induced relapse, immunohistological 
examination of the CNS from EAE-recovered mice was performed. Although the motility of 
EAE-recovered mice was not significantly different from normal healthy mice, the meningeal 
region of the L5 cord of EAE-recovered mice contained a high number of periphery-derived 
Figure 3. Electric gateway reflex. Electric stimulation to the triceps induces chemokine upregulation at the dorsal vessels 
of the fifth cervical (C5) to fifth thoracic (T5) spinal cord through sensory-sympathetic neural activation, which leads 
to activation of the inflammation amplifier at the C5-T5 dorsal vessels. In a similar fashion, electric stimulation of the 
quadriceps and soleus muscles induces a gateway at the L3 and L5 dorsal vessels, respectively.
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monocytes that expressed high levels of MHC class II [18]. These MHC class II high mono-
cytes distributed around the meningeal region of the L5 cord in EAE-recovered mice. After 
pain induction, however, these cells accumulated at the ventral vessels of the L5 cord bilater-
ally. Experimental evidence that (1) norepinephrine signaling could be detected around the 
L5 ventral vessels, (2) MHC class II high monocytes expressed chemokine receptor CX3CR1, 
and (3) MHC class II high monocytes secreted chemokine CX3CL1, a ligand for CX3CR1, after 
norepinephrine stimulation suggested an auto/paracrine loop is responsible for the accumu-
lation of MHC class II high monocytes around the L5 ventral vessels via norepinephrine regu-
lation of the CX3CL1-CX3CR1 axis. Because freshly isolated MHC class II high monocytes 
from EAE-recovered mice have autoantigen (MOG)-presenting capacity without additional 
peptide loading, it can be suggested that MHC class II high monocytes accumulated around 
the L5 ventral vessels would activate pathogenic CD4+ T cells through autoantigen presenta-
tion, followed by regional inflammation and disease relapse. Suppression of norepinephrine 
signaling by a β1 blocker or sympathetic nerve ablation by chemical sympathectomy inhib-
ited the pain-mediated accumulation of MHC class II high monocytes around the L5 ventral 
vessels [19]. These results identified the L5 ventral vessels as the gateway for pain-induced 
relapse in the EAE model (Figure 4). This pain gateway reflex is the third example of the gate-
way reflex following the aforementioned gravity and electric examples.
2.4. Stress gateway reflex
Chronic stresses deteriorate illness, an effect attributed to the proverbs “Illness starts in the 
mind” and “Care killed the cat.” Chronic stress conditions often cause gastric and intesti-
nal diseases via the brain-gut axis. Although these diseases are well known and often expe-
rienced, the underlying molecular mechanisms remain to be elucidated. Stresses generate 
neural activations involving multiple brain areas such as the paraventricular nucleus (PVN), 
dorsomedial nucleus of hypothalamus (DMH), dorsal motor nucleus of the vagal nerve 
(DMX), and vagal nerve pathway [58]. We therefore hypothesized that chronic stresses might 
induce a specific gateway reflex. Indeed, experiments confirmed the stress gateway reflex. We 
serendipitously found that micro-inflammation induced by the stress gateway reflex activates 
an otherwise resting neural circuit to enhance a stress response that causes fatal gastroin-
testinal and heart failure in mice [38]. Therefore, the stress gateway reflex may explain the 
mechanisms for the abovementioned proverbs, as described below.
The gravity gateway reflex directs donor pathogenic CD4+ T cells to the dorsal vessels of the 
L5 spinal cord under normal conditions (Figure 1). However, under chronic stress conditions, 
the cells instead invade specific blood vessels of the boundary area of the third ventricle (3V), 
thalamus, and part of hippocampus [dentate gyrus, (DG)] to establish micro-inflammation. 
Therefore, chronic stresses can alter the location of the immune cell gateway from the L5 
dorsal vessels to specific vessels in the brain. Immunohistochemistry of c-Fos revealed that 
the resulting micro-inflammation led to enhanced neural activations in the PVN and DMH, 
which are stress sensing areas of the hypothalamus. Neural tracing experiments identified 
direct connections via noradrenergic neurons between the PVN and the specific vessels of 
the boundary area of 3V, thalamus and DG. Moreover, these experiments showed direct 
Gateway Reflex: A Neuro-Immune Crosstalk for Organ-Specific Disease Development
http://dx.doi.org/10.5772/intechopen.77112
57
connections via nonnoradrenergic neurons between the specific vessels and the DMH. Since 
the PVN is a key orchestrator of stress signals, its activation is expected to affect specific blood 
vessels via a new noradrenergic neural pathway. Indeed, the expression of chemokines such 
as CCL5 was upregulated at specific vessels in mice with chronic stress alone. CNS-reactive 
pathogenic CD4+ T cells in the blood circulation of the stressed mice sensed the upregula-
tion of CCL5, caused micro-inflammation with peripheral derived MHC class II monocytes at 
specific vessels of the boundary area of the 3V, thalamus, and DG [38]. ATP is released during 
an inflammatory response, but it also acts as a neurotransmitter [59, 60]. The injection of an 
ATP receptor antagonist at specific blood vessels of the boundary area of the 3V, thalamus 
and DG suppressed both neural activation in the DMH and the mortality rate of EAE mice 
with chronic stress. Importantly, the direct injection of ATP or cytokines at these specific ves-
sels, which mimicked the micro-inflammation, induced fatal gastrointestinal dysfunction in 
stressed mice without EAE induction. These results suggest that brain micro-inflammation at 
specific vessels of the boundary area of the 3V, thalamus, and DG activates a resting neural 
pathway through ATP production, thus strongly enhancing the stress response to cause fatal 
gastrointestinal damage via the DMX and vagal nerve activation. These results uncovered the 
stress gateway reflex acting as a direct link between micro-inflammation at a particular site in 
the brain and gastrointestinal homeostasis (Figure 5) [38].
Figure 4. Pain gateway reflex. Pain induces nociceptive sensory nerve stimulation (1, 2), leading to activation of the 
anterior cingulate cortex (ACC), a pain-processing area of the brain (3). Specific sympathetic nerves are then activated (4) 
to induce norepinephrine (NE) release around the ventral vessels of the spinal cords (5). NE around the L5 ventral vessels 
induces the production of chemokine CX3CL1 from MHC class II high (MHC class IIHI) monocytes, further recruiting 
these cells in an auto/paracrine manner (6). MHC class II high monocytes are able to present myelin autoantigens to 
activate pathogenic CD4+ T cells, leading to disease relapse (7).
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Several reports have shown the concurrence of inflammatory bowel diseases and MS [61–65]. 
Moreover, brain micro-inflammations were observed in patients with neurodegenerative dis-
eases such as Alzheimer’s disease and Parkinson’s disease [66, 67], epilepsy [68], and psycho-
logical disorders [69]. We therefore suggest that brain micro-inflammations could regulate 
the homeostasis of organ functions including the brain itself by acting as a switch to stimu-
late resting neural pathways, which could account for the comorbidities observed in many 
diseases.
2.5. Cholinergic anti-inflammatory pathway
The Tracey laboratory has demonstrated using a mouse model of sepsis that the activation of 
vagal nerves, which mainly consist of parasympathetic nerves, suppresses an inflammatory 
response [70]. They revealed that lipopolysaccharide induces norepinephrine release in the 
spleen via vagal and splenic nerves. The norepinephrine stimulates a novel subset of CD4+ 
T cells that express β1/2 adrenergic receptor and produce acetylcholine. The resulting acetyl-
choline then acts on activated macrophages expressing α7 nicotinic receptor to suppress the 
Figure 5. Stress gateway reflex. Chronic stress induces activation of the paraventricular nucleus (PVN) (1). We identified 
neural connections from the PVN to the specific vessels of the boundary area of the third ventricle, thalamus and dentate 
gyrus, which induces micro-inflammation around the specific vessels (2). The resulting micro-inflammation induces 
activation of a neural pathway that connects to the dorsomedial nucleus of hypothalamus (DMH) (3) and dorsal motor 
nucleus of the vagal nerve (DMX) (4), resulting in severe upper gastrointestinal (GI) tract failure via efferent vagal nerves 
(5). The increase of potassium ions (K+) in blood circulation by the upper GI tract failure (6) explains at least in part heart 
failure associated with cardiac myocyte necrosis (7).
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expression of pro-inflammatory factors such as TNFα and HMGB1 (Figure 6) [71–73]. The 
stimulation of macrophages with nicotine inhibits NF-κB activation, but not MAP kinase acti-
vation in response to endotoxin [72]. This cholinergic anti-inflammatory pathway is called the 
“inflammatory reflex” [27–29, 31, 32, 34, 74–76]. In addition to infection, this pathway exerts 
anti-inflammatory effects in various disease models including renal ischemia–reperfusion 
injury, acute kidney injury, pressure overload-induced cardiac hypertrophy and neointimal 
hyperplasia [77–81]. The direct stimulation of C1 neurons in the medullary reticular formation 
induced this anti-inflammatory effect in mice [79], suggesting the involvement of C1 neurons 
between afferent and efferent vagal nerves. Activation of the cholinergic anti-inflammatory 
pathway can be induced by acupuncture and ultrasound, thus inhibiting the pathology of ani-
mal models [82, 83]. These findings establish a scientific basis for acupuncture and physical 
therapy. In addition, activation of the inflammatory reflex through vagal nerve stimulation by 
an implantable device has been tested in humans for chronic inflammatory diseases including 
rheumatoid arthritis with promising results [84, 85].
Figure 6. Inflammatory reflex. Afferent (1) and efferent vagal nerve (2) activation by infection, and so on induces neural 
activation in the celiac ganglion (3), followed by the production of norepinephrine (NE) by the splenic nerves (4). NE 
stimulates the release of acetylcholine (ACh) from a subset of CD4+ T cells expressing β1/2 adrenaline receptor (AR) 
(5). Then, ACh (6) acts on macrophages expressing α7 nicotinic acetylcholine receptor (α7nAChR) to suppress the 
expression of pro-inflammatory factors such as HMGB1 and TNFα. It is suggested that C1 neurons in the brain mediate 
the cholinergic anti-inflammatory effect.
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2.6. Future directions
Accumulating evidence has demonstrated the significant effects of regional neuro-immune 
interactions on organ homeostasis, particularly during inflammation and diseases. The gateway 
reflex and inflammatory reflex can be induced by various stimulations to activate these interac-
tions. Stimulation of the vagal nerves by an implantable device has already shown an anti-inflam-
matory effect in humans [84, 85]. The stimulation of the neurons responsible for the gateway 
reflex and inflammatory reflex at the body surface, as is the case with acupuncture, could lead to 
therapies that are less invasive and less costly, although elucidation of the precise neural circuits 
activated by the reflexes is required. Neural mapping is still challenging, but recent techniques 
and tools including the tissue clearing method CUBIC [86–89], optogenetics and chemogenetics 
[90, 91], and transgenic mice reporting neural circuitry and activations [92–94] will greatly con-
tribute. Because neural circuits run throughout the body and because nonimmune cells as well 
as immune cells [18, 19, 71, 95–97] are able to secrete and respond to neurotransmitters, specific 
regional neuro-immune interactions such as the gateway reflex and inflammatory reflex bear 
potential as a significant therapeutic strategy to recover organ homeostasis.
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